Company profile

DeePathology

Pathology & Laboratory Diagnostics

Company profile

About DeePathology

DeePathology is a health AI company specializing in artificial intelligence solutions for digital pathology and laboratory diagnostics. The company's flagship product, DeePathology® STUDIO, is an interactive do-it-yourself platform that empowers pathologists and researchers to develop custom AI algorithms for histological image analysis without requiring programming expertise. The platform leverages state-of-the-art deep learning and neural networks to enable rapid creation of proof-of-concept solutions, often within minutes, using minimal training data. DeePathology® STUDIO supports multiple analysis modes including object segmentation, cell detection and classification, region segmentation, and tile classification. The platform's innovative Deep Interactive Online Active Learning approach allows users to annotate thousands of cells in days rather than weeks, dramatically accelerating dataset creation. The software runs locally on users' computers, ensuring data privacy and security without requiring slides to be sent to remote servers. Beyond its DIY platform, DeePathology offers ready-to-use AI applications including diagnostic decision support systems for Helicobacter pylori detection in gastric biopsies and tuberculosis detection in tissue samples. The company also provides professional R&D services for custom algorithmic challenges such as drug outcome prediction and visual search engines. DeePathology serves academic researchers, pathology labs, and healthcare institutions globally, with particular focus on applications in oncology, neuropathology, and infectious disease diagnostics. The company supports all major whole slide imaging formats and integrates with existing pathology workflows.

Company description DeePathology official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at DeePathology?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Alzheimer's disease (beta-amyloid plaques)
  • Cancer/Oncology (tumor infiltrating lymphocytes, tumor regions, glandular structures, mitotic figures, skin cancer)
  • General pathology (cell quantification, tissue segmentation)
  • Infectious diseases (Helicobacter pylori, Mycobacterium tuberculosis)

Who it serves

  • Academic researchers
  • Healthcare providers
  • Pathology laboratories
  • Research institutions

Deployment & integration

Hybrid · On Premise · Other deployment with recorded integration context.

Geographic context

MarketsGermany · Global (implied) · Israel · Spain
Company sourceOfficial website

Company milestones

Platform expansion

Development of H. Pylori Decision Support System and TB Decision Support System; multiple academic collaborations

Partnerships

Recorded partners

  • Institute for Pathology Cologne, Germany
  • Vall d'Hebron Institute of Oncology

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

DeePathology® STUDIO

DIY AI platform for pathologists to develop custom AI solutions for histological image analysis on their own laptop

Software · On PremiseCompany source

H. Pylori Decision Support System

AI screening tool for detecting Helicobacter Pylori bacteria in gastric biopsies with 100% sensitivity

Software · OtherCompany source

Professional Services

Custom AI R&D services for pathology challenges including drug outcome prediction and visual search engines

Service · HybridCompany source

TB Decision Support System

AI detector for identifying tuberculosis in biopsies within 10 seconds

Software · OtherCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

100% sensitivity

H. Pylori Decision Support System designed as screening tool

10 seconds analysis time

TB detection in slides (vs 40-60 minutes manual examination)

Annotation speed improvement

Annotate in 10 minutes what would take days; thousands of cells in days vs weeks

5 minutes proof of concept

Create PoC solutions for most problems in 5 minutes

Institute for Pathology Cologne, Germany

Development of automated Helicobacter Pylori detection in gastric biopsies

First ever automated H. Pylori detector software on gastric biopsies with 100% sensitivity, scanning entire slides within seconds

Vall d'Hebron Institute of Oncology

H&E TMA analysis for cell density quantification in tumor regions

Successful creation of AI algorithms for powerful analytics like cell density in tumor regions

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from DeePathology

Recent articles published on DeePathology's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon